The new service is being headed by Dr Katia Marioni-Henry.
Katia graduated from the University of Parma in 1995 and went on to do a PhD in Clinical Electrodiagnostic at the University of Turin and Scott-Ritchey Research Center in Auburn, Alabama.
Her early career was spent at various American universities, where she became a Diplomate of the American College of Veterinary Internal Medicine, with a subspecialty in Neurology and finally an Assistant Professor of Neurology and Neurosurgery at the University of Tennessee.
Katia came to the UK to work as a consultant in neurology and neurosurgery for a number of large referral practices, before moving to the University of Edinburgh in 2013, where she started the neurology/neurosurgery service, building it from scratch to a nine-strong team.
Katia said: “This is absolutely the best place to be brought in an emergency, but previously we’d have to refer some cases elsewhere for conditions affecting the brain, peripheral nerves or the spine.
“Now some of these debilitating neurological conditions can be diagnosed and treated rapidly here without having to transport the animal.”
“With our CT scanner, for example, we can diagnose slipped discs quickly, especially in small breeds, and treat them surgically.
“And we can use it for brain scans if there is trauma or if we suspect a tumour or severe inflammation in the brain.
“We can do a lumbar tap to rule out inflammation of the central nervous system either on infectious or immune-mediated basis.”
The speaker line-up includes performance coach and head of training at VDS training, Carolyne Crowe, Jamie Callan, Professor of Leadership & HRD and Director of Equity & Diversity at Newcastle Business School and Laura Whyte, who was HR Director at the John Lewis Partnership and is now a Non-Executive Director with a number of organisations including XLVets, the British Horseracing Authority and the Ministry of Defence.
A number of women from industry and practice will also share their experiences and perspectives in short sessions entitled ‘If you can see it, you can be it!’ to reflect how veterinary women can tackle challenges and make the most of opportunities.
The event is being steered by Liz Barton, the editor of Veterinary Woman, and Kerrie Hedley, the Chief Operating Officer at XLVets. Liz said: “We’ve been working hard to develop resources for women in the profession for the last few years and it’s wonderful to see so many women coming together and providing the skills and inspiration that will help other women aspire to leadership roles.”
Kerrie, who will be running a workshop on 'Overcoming Stereotypes: What does the future leader look like?' added: "From the research I undertook last year we know that there is a stereotypical perception of what a leader looks like in the profession, for example a requirement to work full time. This workshop is about crushing that stereotype and defining what the future leader could look like. I'm really excited to be supporting women to develop innovative solutions in their leadership journey and look forward to seeing what we can achieve at this inaugural event."
The event is open to anyone in the profession – vets, RVNs, practice managers, whether from independent or corporate practice, industry or academia. Registration costs £45, inclusive of VAT and £20 for students if booked at the early bird rate before 31st August.
Recordings will be available to anyone who registers but can’t attend the whole six hours.
Registration is now open at https://bit.ly/VeterinaryWomenInLeadership.
Nebojsa Petrovic faced eight charges, although charge four was withdrawn at the start of the hearing.
At the outset of the hearing, Dr Petrovic admitted a number of allegations, including:
Charge 1 - that in November 2021, he falsely represented to the Animal and Plant Health Agency (APHA) that blood samples he submitted in respect of four horses were from the same horses as the samples he submitted on 1 November 2021.
Charge 2 – that in November 2021, he told APHA’s Veterinary Head of Border Control that he had checked the microchips and/or passports of the four horses when he hadn’t done so;
Charge 3 – that in November 2021, he signed Export Health Certificates for the four horses, in which it was stated that blood samples taken from these horses on October 2021 had been submitted to the Veterinary Laboratories Agency laboratory, Weybridge, with a negative result for Leptospirosis when in fact those samples had tested positive;
Charge 5 – that he failed to send the APHA’s Centre for International Trade, within seven days of signing, certified copies of the export health certificates;
Charge 7 – that in January 2022, he told an APHA officer that he was satisfied that he had properly identified the horses for which you had submitted the two samples when he had not done so;
Charge 8c – that he risked undermining government procedures designed to promote animal health and international relations in relation to the charges he admitted; and
Charge 9 – that in February 2022, he failed to have in place any or any adequate Professional Indemnity Insurance (PII).
Dr Petrovic, who was at the time of all the allegations carrying his duties as an Official Veterinarian on behalf of the APHA, denied charge 6 – that in November 2021, he failed to take sufficient steps to prevent the four horses being exported to Serbia, when he had been informed that there were concerns and/or doubts about whether those horses had tested negative for Leptospirosis.
He also denied charge 8 – that in relation to the allegations relating to his submitting the blood samples to the Veterinary Laboratories Agency on 8 November 2021, certification of the Export Health Certificates on 16 November 2021 and his subsequent conversations with members of APHA staff regarding both sets of documentation he had acted in a misleading (Charge 8a) and/or dishonest (Charge 8b) way.
The Committee considered evidence presented by the College including hearing from APHA staff witnesses called by the College and also hearing from a witness and character evidence presented by Dr Petrovic. Dr Petrovic also gave evidence to the Committee.
It found most charges proven with the exception of Charge 6, and also found that Dr Petrovic had not acted dishonestly in submitting the blood samples or certifying the EHC’s as alleged in charges 1 and 3.
The Committee concluded that Dr Petrovic had acted in a dishonest and misleading way in his conversations with the APHA staff as detailed in charges 2 and 7.
The Committee then considered whether the individual proven charges amounted to serious professional misconduct, determining that, with the exception of charges 3 and 5, all proven charges amounted to disgraceful conduct.
Paul Morris, chairing the Committee and speaking on its behalf, said: “In the Committee’s judgement, the respondent’s position as an Official Veterinarian also meant that he had a responsibility to ensure that the trust which was delegated to him was not breached.
"In his role, the respondent was acting in a position of trust, as a representative of the government, and the Committee found that he had breached that trust…. It took these matters into account when determining that the respondent’s behaviour cumulatively amounted to disgraceful conduct in a professional respect.”
Regarding the sanction for Dr Petrovic, the Committee considered his request that it consider suspension, rather than removal, from the Register.
In terms of aggravating factors – the Committee found that Dr Petrovic had acted without integrity, recklessly and without regard for the APHA’s systems relating to the export of animals.
In mitigation, it took into account: the fact that no animal was harmed by his conduct, albeit there was risk of harm; his long and unblemished career in the UK since 1994; admissions he had made to the APHA and Disciplinary Committee at the first day of the hearing; had remediated his lack of professional indemnity insurance by putting in place a retrospective policy; the significant amount of time that had elapsed since the conduct; and six positive character references from experienced fellow veterinary surgeons who held him in high regard.
Paul Morris added: “The Committee took into account that the respondent had continued to work as a veterinary surgeon with no subsequent complaints and that he had a previous long and unblemished record and there was support by several positive character references.
"The Committee also took into consideration the pressures of Brexit and the pandemic which the respondent had faced at the time, but which were unlikely to occur again.
“The Committee had concluded that the respondent was unlikely to repeat similar behaviour or to pose a risk to animals, particularly because he was no longer involved in certifying animals for export.
"Furthermore his admissions to most of the matters it had found proved showed that he had some insight.
"The Committee was also satisfied that the respondent had a genuine concern for the welfare of animals and it noted that the Respondent did not require any further training to continue in practice as a veterinary surgeon.
“The Committee therefore concluded that a suspension from the Register was the proportionate sanction in this case taking into account the seriousness of the conduct it had found proved but also all of the mitigating factors.”
The Committee recommended that Dr Petrovic be suspended for six months to reflect the seriousness of the conduct and the damage it could do to public confidence in the profession, while meeting the public interest and sending a clear message of deterrence.
www.rcvs.org.uk/disciplinary
Matthew’s award is in recognition of his paper Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom, co-authored with Laurent Garosi, which was selected by the BSAVA Committee as being the most valuable to veterinary practice.
James’ study explored data collected as part of the Small Animal Veterinary Surveillance Network (SAVSNET) at the University of Liverpool.
In total, clinical records concerning 3,150,713 consultations (917,373 dogs) were collected and analysed from 224 UK veterinary practices.
This included the management of canine generalised epileptic seizures in 517 dogs up to 6 years of age.
The study concluded that 98% of dogs presenting for a single epileptic seizure were not started on long-term therapy, in accordance with the approach recommended by the International Veterinary Epilepsy Task Force (IVETF).
Other findings from the study included:
The paper also reported on factors potentially associated with prescription of ASDs.
It stated that dogs who presented for cluster seizures (more than one epileptic seizure in a 24-hour period) were more likely to be prescribed ASDs, or to be referred to a specialist, than dogs without cluster seizures.
Dogs that were neutered or microchipped were more likely to be started on ASDs following the initial presentation, perhaps suggesting that owners who take part in regular preventative healthcare prior to the onset of their dog’s seizures could be more willing to start therapy in the earlier stages of the disease.
In addition, more than half of dogs with cluster seizures were not prescribed any ASDs.
Given that the presence of cluster seizures is typically considered an indication to start long-term therapy by the IVETF, Matthew says this may be one aspect of seizure management that could be improved in primary care practice.
Regarding the choice of anti-seizure drugs (ASDs), imepitoin was more frequently prescribed than phenobarbital in response to cluster seizures.
But unlike phenobarbital, the paper highlighted that the market authorisation for imepitoin does not include the treatment of cluster seizures.
Therefore vets should be aware that the use of imepitoin for cluster seizures should be considered as “off-licence” - and has additional implications for obtaining informed consent.
Matthew said: “We believe this research contributes to an improved understanding of the current management strategies for canine epilepsy in general practice and how this compares to the current guidelines advised by the IVETF.
"Given the prevalence of epileptic seizures within the UK canine population, as well as the large proportion of dogs that will be managed entirely within general practice without referral to a neurologist, it is vital to ensure that the level of care being provided is optimal.
"We therefore hope that this research ultimately supports and guides general practitioners in their approach to canine epilepsy, thereby improving the quality of life of affected dogs and their owners.”
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13543
Sally Linghorn, Senior RVN at CVS and one of the team behind the initiative, said: “As far as we know, no other veterinary company has policy, support and specific training and guidance on this topic, in our female-biased profession.”
“We recognise how devastating pregnancy loss can be.
"Last year we launched a policy to provide special paid leave for pregnancy loss.
"But since implementing this we have noticed a gap.
"We felt our managers needed guidance and support on how to provide the more practical and emotional support on a day-to-day basis, if someone in their team experienced a loss."
The new guidance contains advice on how to understand each individual’s experiences and needs, help in the immediate situation of pregnancy loss at work, treat and record any time off directly related to a loss, understand how pregnancy loss can affect mental health, talk about pregnancy loss, facilitate a return to work and the importance of regular follow-ups and check-ins.
The webinars are open to veterinary clinics across the UK and the US, including those not affiliated to Premier Vet Alliance.
The programme is as follows:
Jo Wells, Premier Vet Alliance’s Business Relationship Manager said: “We’ve concentrated on providing a blend of practical advice and insights, people management support and also some inspiring motivational ideas.
“Because we operate globally, we’ve engaged speakers from both sides of the Altlantic which presents insights into alternative ways of working and thinking. We’ve also kept the webinars to just an hour-long in length so they are time efficient.
“As well as providing what we hope will be valuable content, the webinars will also encourage a platform for networking and on-going communication.
To register for the first event on Thurday 24th February, visit: https://tinyl.io/5ZtP
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
The VetCompass programme studied 10,313 English Cocker Spaniels from an overall sample of 336,865 UK dogs of all breeds under first opinion veterinary care during 2016.
English Cocker Spaniels made up 3.1% of all dogs, showing ongoing high popularity of this breed as a UK companion animal.
The most common disease was periodontal disease, diagnosed in 20.97% of English Cocker Spaniels each year.
In second place was otitis externa (10.09%), followed by obesity/overweight (9.88%), anal sac impaction (8.07%), diarrhoea (4.87%), and aggression (4.01%).
The order of these top disorders in English Cocker Spaniels was similar to those previously reported in dogs overall; however, the frequency of each disorder was generally higher in English Cocker Spaniels than the general dog population, possibly because several of these conditions are related to the longer ears and looser skin on English Cocker Spaniels.
Researchers say these results suggests that English Cocker Spaniels can be considered a typical dog in many respects, but with higher risk of some disorders related to their specific body shape.
Aggression was found to be relatively common in English Cocker Spaniels, although the frequency differed depending on the sex and coat colour of the dogs: aggression was more common in males than females, and in single-coloured than multi-coloured dogs.
The risk of aggression also varied widely between the four most common single-coloured coat colours: golden-coloured dogs showed the highest frequency of aggression (12.08%), followed by red (6.52%), black (6.29%), and liver (4.33%).
Additional findings include:
Karolina Engdahl, Epidemiologist at the Swedish University of Agricultural Sciences and lead author of the paper, said: “English Cocker Spaniels are popular family dogs and can make fantastic pets.
"However, we found that aggression was relatively common in the breed, especially in golden-coloured dogs.
"This highlights the importance of focusing good breeding on behavioural as well as physical health, and that behavioural-related problems should be a key area for veterinary-owner discussions.”
Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, co-author of the paper, said: “Everyone who loves dogs just wants their animals to live long and happy lives.
"This study provides the data to help owners to understand that preventing dental, ear, weight and anal sac problems can go a long way to helping English Cocker Spaniels to enjoy a better life.
"It really can be that simple.”
The Equine Nursing Committee is comprised of members of CVS Equine Nursing practice teams from across the country, supported by senior nursing team members within CVS Group.
The committee’s remit will be for nurses to review and appraise the evidence supporting new-to-market therapies, appraise treatments and equipment, and guidance for practice-level decisions.
CVS says the group will also identify and share the most important clinical developments, provide technical knowledge and feedback on clinical policy, update clinical guidelines and disseminate the clinical decision-making process.
The group is also tasked with developing nursing career pathways and student nurse support programmes, creating psychologically safe working environments and forming support programmes for nurses.
Kit, or, to give him his full title, Dr Kit Sturgess MA, VetMB, PhD, CertVR, DSAM, CertVC, FRCVS, RCVS Recognised Specialist in Small Animal Medicine, has been working as an internist in private referral practice since 2003. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
He is also Chair of BSAVA Education Committee, Trustee of Cats Protection and Chair of Trustees of the Wildheart Trust. He was formerly an RCVS Knowledge Trustee and member of RCVS Council.
Kit has authored numerous articles and two textbooks, and presents lectures and research abstracts at conferences worldwide.
Kit will take up the editorship on 2nd September, succeeding Professor Peter Cockcroft. He said: “I am delighted to take on the editorship of Veterinary Evidence. With readers in 150 countries and output that has more than doubled over the past three years, the journal has quickly become a mainstay of evidence-based veterinary medicine, which is a testament to Peter’s enthusiasm and commitment to the development of the journal and its impact on the veterinary community.
"I am excited about leading Veterinary Evidence in its next stage of development, with recent events showing the critical importance of open online access. Veterinary Evidence is ideally placed to support an ever-growing and wide range of veterinary professionals by further developing a multimedia, multiplatform approach facilitating the use of evidence-based medicine in their daily practice."
Veterinary Evidence journal can be read at: veterinaryevidence.org
On hand to answer your questions is Adam Gregory, RVN NCert (Anaesth) DMZAA DipVNZS APVN, Head Nurse at Great Western Exotics.
Before putting your questions to Adam, you're invited to read his article on the subject here: https://www.veterinary-practice.com/article/pain-management-in-the-avian-patient
Then join the Clinical Article Club here: https://www.vetnurse.co.uk/vetnurse-clinical-article-club and post your question or discussion point in the forum.
Remember, you can claim time spent reading or participating in the discussion towards your annual CPD requirement: press the 'Claim CPD' button at the top right of the discussion thread.
The double-blind placebo-controlled study will examine whether the pheromone collar can help reduce the severity or development of certain potentially problematic behaviours in puppies and it is open to puppies less than 12 weeks of age.
Puppies will have to wear a collar until they are six months of age and their owners will be asked to complete a check sheet relating to their puppy’s behaviour every month. Each month a new collar will be sent direct to their home.
To encourage enrolment, the University of Lincoln is offering veterinary professionals a £10 voucher for every successful sign up to the trial.
Owners who complete all questionnaires will receive a pack of canine health and welfare goodies from Ceva Animal Health. The pack will include Adaptil Junior, Adaptil Transport and Logic Oral Hygiene Gel.
Owners will also be entered into a draw to win an iPad.
A marketing pack is available to raise awareness of the study and includes a waiting room poster, owner leaflets and a social media post for Twitter, Facebook or Instagram.
For further information, email the University of Lincoln at puppydevelopment@lincoln.ac.uk.
The ophthalmology service, which offers cataract surgery, corrective eyelid surgery and corneal disease management amongst other things, is headed by RCVS and US Ophthalmology Specialist, James Histed (pictured right)
The hospital, which has doubled in size to 30,000ft², now has a purpose-built theatre complex, a new reception and waiting area, 12 additional consulting rooms and a new rehabilitation centre equipped with a water treadmill and a large arena for treatment and gait analysis.
It also has a new lecture theatre where SCVS can deliver its CPD programme and parent company IVC can deliver its intern and residency programme.
The company says that its redevelopment has focused on employee wellbeing, to which end there is a new staff area for the 200-strong team a place to gather, dine and relax.
Kennel space for staff dogs has also been increased to support SCVS’s ‘bring your dog to work’ policy.
The new hospital facility is fully operational and open 24/7 for referrals, supporting colleagues from surrounding vet practices.
www.scvetspecialists.co.uk
The company’s NEMO Cardiac Health Screening test detects heart disease using AI to analyse microRNAs - biomarkers that manage the immune system and its responses and act as regulators for disease progression or resolution.
MI:RNA says the new test, which can be taken from blood or urine samples, will help vets diagnose and monitor disease progression more effectively and give cats and dogs with heart disease 18 months more life.
Eve Hanks, CEO and founder of MI:RNA (pictured) said: “The use of precision medicine in veterinary diagnostics will help pet owners and breeders alike to ascertain where to direct their efforts and finances accordingly.
"There is massive potential to use this technology to help breeds who have real problems with heart and other diseases, and will consequently help owners and breeders to identify affected animals more quickly.
Professor Joanna Dukes-McEwan, Head of the Cardiology Service at the University of Liverpool said: "From our cardiac investigations, we knew exactly the underlying heart disease and the severity of this, so our data was used as a training set for the MI:RNA panel analysis.
"We have previously collected samples from dogs with myxomatous mitral valve disease and are currently collecting samples from cats with hypertrophic cardiomyopathy.
“I think the MI:RNA panels are most useful for vets in primary care practice to identify and confirm the severity of underlying cardiac disease in their patients.
"A simple blood test which could confirm that the cause of a heart murmur is MVD, and also indicate its severity, and whether the patient would benefit from treatment would be really helpful for primary care vets in practice.
"They might indicate which patients may benefit from referral, or indicate when a specific treatment is indicated.
"Future research with miRNA panels may also indicate novel pathways in progression of disease which might increase our understanding of the disease, or novel therapeutic options.”
The company has updated its waiting room board kit for veterinary staff to create a visual reminder of the importance of prompt diagnosis and management of dental disease and a tailored dental home care regime.
There is also a Pet Dental Health Month social media pack which includes imagery, videos and copy to use on your practice social media channels and client-facing waiting room screens.
Dental charts are also available to help explain dental aftercare in post-op appointments.
Will Peel, Marketing Manager at Animalcare said: "We know that veterinary staff recognise the importance of oral health, so we’ve created this range of materials specifically to support veterinary practices and to help people better understand how they can maintain good dental health in their pets.’
www.animalcare.co.uk/dentalhealthmonth
There will be 20 presentations from some of the world's leading experts, covering topics such as detection and diagnosis, advances in veterinary oncology, supportive care for the cancer patients, how to build a partnership with pet owners and, of course, feeding the cancer patient.
The presentations will be streamed live and available on demand afterwards, at https://learn.hillsvet.com/en_GB/hills-global-symposium-2023
Dr. Iveta Becvarova, Senior Director of Global Academic & Professional Affairs at Hill's Pet Nutrition said: "This year’s Hill’s Global Symposium will offer the latest advancements and innovations to help veterinary professionals support and counsel their clients, and provide the best care possible to the pets in their care."
Led by Aarti Kathrani, a senior lecturer in small animal internal medicine at the Royal Veterinary College, and Jennifer Larsen, Professor of Clinical Nutrition at the University of California School of Veterinary Medicine, the presentation will focus on how veterinary professionals in general practice can manage nutritional recommendations for patients that have two or more health conditions with competing or overlapping nutritional needs.
During the webinar, Aarti and Jennifer will share practical insights into making effective clinical decisions when selecting diets for patients with multiple conditions and reflect on how this can support the management of these cases.
They will explore scenarios where the optimal diet for one condition may not be suitable for a concurrent condition, requiring clinicians to prioritise.
The speakers will also address how nutrition and feeding management can be modified to ensure medication delivery without compromising therapeutic efficacy.
The webinar will also address the issue of pet owners seeking non-veterinary recommendations or relying on internet research for advice (something which apparently 78.6% of pet owners do1).
https://webapp.spotme.com/login/eventspace/CollaborativeCareJuly2023
Reference
The survey was held between the 1st and 5th May and was sent to the 3,139 UK veterinary practices for which the RCVS holds a unique email address. In total it gathered 251 responses (a response rate of 8%) compared to the 532 responses to the initial survey conducted between 3rd and 7th April (a response rate of 17%).
The main changes compared to last month's survey were:
Lizzie Lockett, RCVS CEO, said: "This latest survey has identified some positive trends in terms of a slight uptick in business, including turnover, and fewer incidences of staff having to take time off with COVID or COVID-like symptoms.
“I am glad to see that the framework we published in April has, so far as we can see, provided veterinary professionals with greater guidance and reassurance regarding the fact that if it is feasible to do something safely under social distancing guidelines, then they can go ahead, if they choose to.
"We left plenty of scope for veterinary professionals to use their clinical judgement as to what services actually offer, depending on their facilities, level of staffing, availability of protective equipment, local disease pressures and so on.
"However, it is also clear that we are, by no means, out of the woods and that veterinary businesses are still struggling financially, with some of them reporting a very acute impact of the coronavirus and the associated restrictions on their businesses.
“We will continue to monitor the situation via these regular surveys, with the next one planned for early June. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected. This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
The new Veterinary HPM Adult Neutered Wet with Salmon (a lifestage diet) and Urology Cat Wet (a clinical diet) have a high-protein low-carbohydrate formulation and a high share of animal protein.
Virbac points to studies which show that FLUTD is diagnosed in 8% of cats seen by vets for non-routine appointments1 and that there is a 51% risk of recurrence within one year of the initial diagnosis2.
Dr Rémi Mandray DMV MRCVS, Product Manager at Virbac, said: "Feline specialists recognise the importance of nutrition and water intake in the management of FLUTD, so we are delighted to be able to add two high quality wet diets to the Veterinary HPM range and therefore offer advanced nutritional solutions to such an important health issue."
Virbac says that both diets have high levels of animal protein to stimulate water intake, increase the volume of urine and stabilise the pH for a healthy urinary system.
The lifestage diets include supplements to limit phosphorus excretion in the urine for improved prevention of struvite crystal formation.
The company also says the Urology diets in the clinical range meet the PARNUT requirements for dissolution and prevention of struvite stones or crystals, and prevention of oxalate formation.
Virbac claims the new chunks in gravy wet diets naturally increase water intake by up to 50%, due to their high water content.
Dry and wets can be fed together as part of a mixed nutritional programme, to meet pet owner preferences identified in Virbac's market research: 60% of cat owners use wet food, mostly mixed with kibbles4.
For more information, contact your Virbac Territory Manager.
References
Only two nominations have been received for the RCVS Veterinary Nurses Council and there were two places up for contest, so there will be no VN Council election this year.
The two places will be filled by Hilary Orpet and Suzanne May. Hilary is a Lecturer in Veterinary Nursing at the Royal Veterinary College, and will start her second four-year term on Council. Suzanne is Head of the Veterinary Nursing Approved Centre and Senior Lecturer at Harper Adams University College.
The pair will take up their positions formally on RCVS Day in July.
Liz Branscombe, Chairman of the VN Council said: "Although I am delighted that Hilary remains on Council, and look forward to welcoming Suzanne, I am disappointed that so few VNs took the opportunity to stand for election. For VN Council to remain relevant to all VNs, it is important that as many VNs as possible engage with the political process".
The company says it has renamed the product to better reflect its main use, which is for maintaining skin and coat health in cats and dogs.
Chris Jones, Managing Director at Nutravet said: “We’re continually looking at ways to improve our product offering, which includes ensuring our product range can be discussed with ease between veterinary professionals and pet owners.
"Nutracoat has been used in international markets since launch, and we now feel that the natural progression is to mirror transition the use of Nutramega to Nutracoat in the UK."
www.nutravet.com
For the 10,000 steps challenge, the practice has split into teams of eight which will compete against each other for a weekly prize for the team that collectively walks the furthest.
The practice is also encouraging colleagues to participate in daily wellbeing sessions, including interval training and a mindfulness programme, in conjunction with healthcare partner Vitality.
Mark Goodfellow, Head of Oncology at Davies and Mental Health First Aider said: “Commitment to high standards and dedication to patient care can lead to long working hours.
"Couple this with sick patients, distressed clients and end of life decision-making and the outcome can be feelings of failure, hopelessness and compassion fatigue.
"Simply taking time to walk and share experiences with a colleague can be an unburdening in itself. A problem shared with the right person is a problem halved.”
The initiative was launched by the RCVS and the BVNA in 2016 to identify and find solutions to some of the specific issues facing the veterinary nursing profession.
In July 2016 it published the VN Futures Report and Action Plan which set out 31 actions under six broad strategic aims.
To follow up these actions, six working groups were formed to look at the broad strategic areas and, in June 2018, it was decided to set up a VN Futures Board to help coordinate and oversee the work of these groups. The Board comprises the RCVS Veterinary Nurses Council Chair and Vice-Chair, Racheal Marshall and Liz Cox, and the BVNA President and Vice-President, Wendy Nevins and Jo Hinde.
Outgoing Chair Wendy Nevins said: "In its first 12 months, the VNF Board has really got to grips with the direction and legacy of the VN Futures initiative. The clarity and direction it has brought is reinvigorating the Working Groups. The next 12 months will see a real focus on delivery of the original findings of the VFN Futures initiative."
The VNF initiative is nearly three years into its original five-year life span and the Board reported that progress thus far has included the development of two new Diplomas in Advanced Veterinary Nursing, more resources to help both VNs and vets navigate Schedule 3 and publication of career case studies to demonstrate the diverse roles available in the profession.
Wendy added: "The VN Futures project has a fixed five-year horizon to make sure we keep focus on what the profession said it wanted – and needed – to be delivered. At the end it will be for the profession to decide how well this has been done – and what comes next."
The Board also confirmed plans to have a presence at the Royal Veterinary College’s Student Veterinary Nurse Fest this summer, as well as events at the BVNA Congress in October and the British Small Animal Veterinary Association Congress in April 2020.
Racheal Marshall said: "The energy and life of the VN Futures initiative comes from veterinary nurses so we are excited to be taking this back out to meet nurses and ask them for their thoughts and comments on how these issues – like career progression, further qualifications, and emerging agendas like One Health – matter to them. We are really looking forward to a busy program of congress events in order to hear from people!"
To download the VN Futures Report and Action Plan and view some of the initiative’s latest blogs, case studies and other online resources, visit: www.vetfutures.org.uk/vnfutures/
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”